The source framing identifies focused ultrasound as one of the non-invasive modalities discussed for pain relief.
First-pass extracted concept
focused ultrasound
Candidate: concept label12 source documents24 linked claims
Live refresh every 5sNext refresh in 5s
Aliases
FUS, LIFU, low-frequency, low-intensity focused ultrasound
Extracted Explainers
What the tool is doing
Focused ultrasound is presented as an incisionless, minimally invasive technique used to treat epilepsy. The review frames it as an emerging modality within the epilepsy surgery landscape.
The study reports that low-frequency, low-intensity focused ultrasound increases membrane tension and activates TRAAK and MscS.
Focused ultrasound is described as a non-invasive technology associated with renewed interest in lesioning procedures for Parkinson's disease.
Resources required
What problem it solves
It is presented as a non-invasive approach relevant to pain-focused neuromodulation.
It addresses the need for less invasive treatment options in drug-resistant epilepsy, especially where fear of open surgery may limit uptake.
It provides a way to connect ultrasound exposure to membrane-tension-mediated activation of mechanosensitive channels.
It offers a non-invasive route for lesioning-based surgical treatment.
What it does not solve
The abstract does not establish definitive efficacy across epilepsy indications and explicitly states that higher level evidence is still needed.
The abstract does not establish broad therapeutic performance or general activation of all mechanosensitive K2P channels by ultrasound.
Alternatives
The article states that focused ultrasound is compared with other alternatives to open epilepsy surgery, but the abstract does not name those alternatives.
The abstract contrasts ultrasound-linked activation with direct quantitative characterization using patch-clamp recording and imaging.
The abstract contrasts focused-ultrasound-enabled lesioning with deep brain stimulation.
Evidence Snippets
Focused ultrasound is rapidly emerging as a novel technology for the development of symptomatic therapies and supporting disease-modifying treatments for Parkinson's disease (PD).
This review systematically traces the technological evolution of stereotactic ablation, including radiofrequency ablation, laser interstitial thermal therapy, radiosurgery, and focused ultrasound.
Focused ultrasound (FUS) offers a non-invasive alternative capable of achieving localized and deep tissue heating.
The editorial explicitly names focused ultrasound as a component intervention class covered in the Research Topic on non-invasive therapy for pain relief.
One such technique is focused ultrasound (FUS), a rapidly evolving, incisionless, image-guided therapy that allows physicians to precisely target specific brain regions with ultrasonic energy to achieve a range of therapeutic effects.
Focused ultrasound is an incisionless, minimally invasive technique that has been used to treat epilepsy.
Focused ultrasound (FUS) is a noninvasive, image-guided therapeutic technology with growing potential for treating facet joint arthritis
Focused ultrasound is a noninvasive, image-guided therapeutic technology with emerging promise for the treatment of facet joint arthritis
Especially, IMP305 combined with focused ultrasound achieved the most pronounced therapeutic benefit.
The abstract states that low-frequency, low-intensity focused ultrasound increases membrane tension to activate TRAAK and MscS.
focused ultrasound (FUS), which can penetrate deep and induce localized hyperthermia for transgene activation
Modern technologies allow focusing ultrasound through the human skull for highly focal tissue ablation, clinical neuromodulatory brain stimulation, and targeted focal blood-brain-barrier opening.
There has been a renewed interest in lesioning procedures secondary to the introduction of focused ultrasound, a non-invasive technology.
Supporting Sources
Linked Claims
Parkinson's disease includes both circuit dysfunctions and molecular pathology, beyond dopaminergic cell loss.
Preclinical advances support the potential of focused ultrasound to become a disease-modifying treatment for Parkinson's disease.
Thermal sonogenetics uses focused ultrasound-mediated localized deep tissue heating to activate genetically engineered cells through heat-responsive promoters.
Quoted textsource-backed
Focused ultrasound (FUS) offers a non-invasive alternative capable of achieving localized and deep tissue heating, enabling precise activation of genetically engineered cells through heat-responsive promoters, a strategy termed thermal sonogenetics.
The review covers the technological evolution of stereotactic ablation modalities including radiofrequency ablation, laser interstitial thermal therapy, radiosurgery, and focused ultrasound.
Quoted textsource-backed
This review systematically traces the technological evolution of stereotactic ablation, including radiofrequency ablation, laser interstitial thermal therapy, radiosurgery, and focused ultrasound.
The review evaluates underlying mechanisms, therapeutic efficacy, and safety profiles of stereotactic ablation techniques for treatment-resistant obsessive-compulsive disorder.
Quoted textsource-backed
In addition, it provides a comprehensive evaluation of the underlying mechanisms, therapeutic efficacy, and safety profiles associated with these techniques.
Focused ultrasound is emerging as a technology for symptomatic therapies and for supporting disease-modifying treatments in Parkinson's disease.
Focused ultrasound has already been clinically applied for targeted brain ablation using high-intensity focused ultrasound and for neuromodulation using low-intensity focused ultrasound, while sonogenetics and BBB-targeted drug delivery are presented as emerging translational opportunities.
Quoted textsource-backed
Currently, FUS has been clinically applied for targeted brain ablation (high intensity [HIFU]) and neuromodulation (low intensity [LIFU]), with recent basic science applications of sonogenetics and targeted drug delivery through the BBB (Precise Intracerebral Noninvasive Guided, or PING, Surgery) offering new opportunities for clinical translation.
Focused ultrasound is a versatile, minimally invasive option for patients with contraindications to or concerns with open surgery or radiation exposure.
Quoted textsource-backed
Focused ultrasound serves as a versatile, minimally invasive option for patients with contraindications to or concerns with open surgery or radiation exposure.
Focused ultrasound is presented as having enhanced safety, patient compliance, and repeatability relative to RF neurotomy and other invasive conventional interventions.
Focused ultrasound may reduce undertreatment risk associated with suboptimal needle placement in radiofrequency procedures.
Literature comparisons indicate that focused ultrasound achieves comparable or superior pain relief relative to radiofrequency neurotomy for facet joint back pain.
Comparative analysis from literature review for RF neurotomy indicates focused ultrasound offers similar or superior efficacy, with pain relief of at least 50% in 80 to 85% of cases at 6 months.
The review identified 15 focused ultrasound-mediated blood-brain barrier opening studies for epilepsy, all of which were preclinical.
Quoted textsource-backed
with respect to FUS-mediated blood-brain barrier (BBB) opening studies, 15 were identified, all of which were preclinical studies.
The review included 46 published articles and 9 ongoing clinical trials on therapeutic focused ultrasound for epilepsy, totaling 55 studies.
Quoted textsource-backed
Forty-six published articles and 9 ongoing clinical trials were included for a total of 55 studies.
Focused ultrasound has the potential to transcend the traditional ablation paradigm and alter the cellular composition of epileptic networks for therapeutic effect.
Quoted textsource-backed
focused ultrasound is an emerging treatment modality that has the potential to transcend the traditional ablation paradigm and alter the cellular composition of epileptic networks for therapeutic effect
Focused ultrasound is an incisionless, minimally invasive technique that has been used to treat epilepsy.
Quoted textsource-backed
Focused ultrasound is an incisionless, minimally invasive technique that has been used to treat epilepsy
IMP305 showed superior antitumor activity in PANC-1 xenograft models, with the strongest benefit when combined with focused ultrasound.
Quoted textsource-backed
IMP305 exhibited a maximal tolerance dose approximately four times higher than that of free exatecan and demonstrated markedly superior antitumor ability. Especially, IMP305 combined with focused ultrasound achieved the most pronounced therapeutic benefit, demonstrating a 49.17 ± 9.00% reduction in tumor volume at day 48 and an 80% survival rate at day 60.
Focused ultrasound is described as an incisionless, image-guided therapy that can precisely target brain regions with ultrasonic energy for therapeutic effects in epilepsy treatment contexts.
Quoted textsource-backed
focused ultrasound (FUS), a rapidly evolving, incisionless, image-guided therapy that allows physicians to precisely target specific brain regions with ultrasonic energy to achieve a range of therapeutic effects
The editorial covers non-invasive pain-relief modalities including transcranial direct current stimulation, scrambler therapy, focused ultrasound, and transcutaneous neuromodulation.
The authors engineered inducible CRISPR-based tools controllable by focused ultrasound for localized transgene activation.
Quoted textsource-backed
Here, we engineer a set of inducible CRISPR-based tools controllable by focused ultrasound (FUS), which can penetrate deep and induce localized hyperthermia for transgene activation.
Low-frequency, low-intensity focused ultrasound increases membrane tension to activate TRAAK and MscS.
Quoted textsource-backed
We further show that low-frequency, low-intensity focused ultrasound increases membrane tension to activate TRAAK and MscS.
Modern ultrasound technologies can be focused through the human skull for tissue ablation, neuromodulatory brain stimulation, and focal blood-brain-barrier opening.
Quoted textsource-backed
Modern technologies allow focusing ultrasound through the human skull for highly focal tissue ablation, clinical neuromodulatory brain stimulation, and targeted focal blood-brain-barrier opening.
Current surgical treatment effectiveness in Parkinson's disease remains limited to motor symptoms such as bradykinesia, rigidity, tremor, and medication-induced dyskinesias.
Quoted textsource-backed
its scope of effectiveness remains limited to motor symptoms like bradykinesia, rigidity, tremor and medication-induced dyskinesias
Focused ultrasound has renewed interest in lesioning procedures for Parkinson's disease because it is non-invasive.
Quoted textsource-backed
there has been a renewed interest in lesioning procedures secondary to the introduction of focused ultrasound, a non-invasive technology